Criminal
Oct. 7, 2011
Johnson & Johnson subsidiary will pay $85 million fine in criminal case
A Johnson & Johnson subsidiary pleaded guilty Wednesday to a misdemeanor violation of the Food, Drug and Cosmetic Act.
By Mandy Jackson
Daily Journal Staff Writer
Scios Inc., a Fremont-based subsidiary of Johnson & Johnson, pleaded guilty on Wednesday and agreed to pay an $85 million criminal fine for a misdemeanor violation of the Food, Drug and Cosmetic Act. Scios promoted its heart failure drug for a use that was not approved by the U.S. Food and Drug Administration, a crime known as off-label marketing.
The company said in a prepared statement that it "denies any wrongful intent ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In